Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Jian Liang ^a   Mazar, Joseph ^a   Zhong, Cuncong ^b   Faulkner, Geoffrey J ^c,d   Govindarajan, Subramaniam S ^a   Zhang, Zhan ^a   Dinger, Marcel E ^e   Meredith, Gavin ^f   Adams, Christopher ^f   Zhang, Shaojie ^b   Mattick, John S ^e   Ray, Animesh ^g   Perera, Ranjan J ^a  

^a BURNHAM INSTITUTE   (United States)

^b University of Central Florida   (United States)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f Life Technologies   (United States)

^g KECK GRADUATE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLUSTER ANALYSIS; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; HUMAN; MELANOMA; NUCLEOTIDE REPEAT; TUMOR CELL LINE;

CELL LINE, TUMOR; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MELANOMA; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 84901829325     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02962     Document Type: Article

References (88)

1. Houghton, A. N.&Polsky, D. Focus on melanoma. Cancer Cell 2, 275-278 (2002)
2. Perera, R. J. & Ray, A. Epigenetic regulation of miRNA genes and their role in human melanomas. Epigenomics 4, 81-90 (2012)
3. Gomez-Sarosi, L. A., Strasberg-Rieber, M. & Rieber, M. ERK activation increases nitroprusside induced apoptosis in human melanoma cells irrespective of p53 status: role of superoxide dismutases. Cancer Biol Ther 8, 1173-1182 (2009)
4. Tsai, K. W. et al. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer 51, 394-401 (2012)
5. Zhang, L. et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103, 9136-9141 (2006)
6. Gaur, A. et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67, 2456-2468 (2007)
7. Fabbri, M. et al.MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104, 15805-15810 (2007)
8. Fazi, F. et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12, 457-466 (2007)
9. Grady, W. M. et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27, 3880-3888 (2008)
10. Lehmann, U. et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214, 17-24 (2008)
11. Mueller, D. W., Rehli, M. & Bosserhoff, A. K. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129, 1740-1751 (2009)
12. Hoek, K. et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64, 5270-5282 (2004)
13. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540 (2000)
14. Carr, K. M., Bittner, M. & Trent, J. M. Gene-expression profiling in human cutaneous melanoma. Oncogene 22, 3076-3080 (2003)
15. Baylin, S. B.DNAmethylation and gene silencing in cancer. Nat Clin Pract Oncol 2 Suppl 1, S4-11 (2005)
16. Loriot, A., Parvizi, G. K., Reister, S. & De Smet, C. Silencing of cancer-germline genes in human preimplantation embryos: evidence for active de novo DNA methylation in stem cells. Biochem Biophys Res Commun 417, 187-191 (2012)
17. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation andmammalian development. Cell 99, 247-257 (1999)
18. Bestor, T., Laudano, A., Mattaliano, R. & Ingram, V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 203, 971-983 (1988)
19. Rothhammer, T. & Bosserhoff, A. K. Epigenetic events in malignant melanoma. Pigment Cell Res 20, 92-111 (2007)
20. Schwabe, M. & Lubbert, M. Epigenetic lesions in malignant melanoma. Curr Pharm Biotechnol 8, 382-387 (2007)
21. Spugnardi, M., Tommasi, S., Dammann, R., Pfeifer, G. P.&Hoon, D. S. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) inmalignant cutaneous melanoma. Cancer Res 63, 1639-1643 (2003)
22. Shenouda, S. K. & Alahari, S. K. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28, 369-378 (2009)
23. Aqeilan, R. I., Calin, G. A. & Croce, C. M. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17, 215-220 (2010)
24. Lynam-Lennon, N., Maher, S. G. & Reynolds, J. V. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84, 55-71 (2009)
25. Schmittgen, T. D. Regulation of microRNA processing in development, differentiation and cancer. J Cell Mol Med 12, 1811-1819 (2008)
26. Chen, A. et al. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol Lett 30, 2045-2052 (2008)
27. Igoucheva, O. & Alexeev, V. MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun 379, 790-794 (2009)
28. Baugh, L. R., Demodena, J. & Sternberg, P. W. RNA Pol II accumulates at promoters of growth genes during developmental arrest. Science 324, 92-94 (2009)
29. Felicetti, F. et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68, 2745-2754 (2008)
30. Schultz, J., Lorenz, P., Gross, G., Ibrahim, S. & Kunz, M.MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18, 549-557 (2008)
31. Bemis, L. T. et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68, 1362-1368 (2008)
32. Felicetti, F., Errico, M. C., Segnalini, P., Mattia, G.&Care, A. MicroRNA-221 and - 222 pathway controls melanoma progression. Expert Rev Anticancer Ther 8, 1759-1765 (2008)
33. Segura, M. F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 106, 1814-1819 (2009)
34. Perera, R. J. & Ray, A. MicroRNAs in the search for understanding human diseases. BioDrugs 21, 97-104 (2007)
35. Chen, C. Z.MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353, 1768-1771 (2005)
36. Dalmay, T. & Edwards, D. R. MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170-6175 (2006)
37. Esquela-Kerscher, A. & Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6, 259-269 (2006)
38. Kent, O. A. & Mendell, J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188-6196 (2006)
39. Zhang, B., Pan, X., Cobb, G. P. & Anderson, T. A. microRNAs as oncogenes and tumor suppressors. Dev Biol 302, 1-12 (2007)
40. Hammond, S. M. MicroRNAs as oncogenes. Curr Opin Genet Dev 16, 4-9 (2006)
41. Han, L., Witmer, P. D., Casey, E., Valle, D. & Sukumar, S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6, 1284-1288 (2007)
42. Saito, Y. et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443 (2006)
43. Lujambio, A. et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67, 1424-1429 (2007)
44. Lujambio, A. et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105, 13556-13561 (2008)
45. Mazar, J., DeBlasio, D., Govindarajan, S. S., Zhang, S. & Perera, R. J. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett 585, 2467-2476 (2011)
46. Mazar, J. et al. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma. PLoS One 6, e24922 (2011)
47. Fang, D. et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65, 9328-9337 (2005)
48. Klein, W. M. et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 20, 102-107 (2007)
49. Berger, M. F. et al. Integrative analysis of the melanoma transcriptome. Genome Res 20, 413-427 (2010)
50. Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502-506 (2012)
51. Wei, X. et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43, 442-446 (2011)
52. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011)
53. Muthusamy, V. et al. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res 66, 11187-11193 (2006)
54. Patterson, K., Molloy, L., Qu, W. & Clark, S. DNA methylation: bisulphite modification and analysis. J Vis Exp DOI:/10.3791/3170 (2011)
55. Shann, Y. J. et al. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res 18, 791-801 (2008)
56. Oster, B. et al. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer 129, 2855-2866 (2011)
57. Li, Z. et al. High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers. Med Oncol 27, 998-1004 (2010)
58. Bogdanovic, O. & Veenstra, G. J. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 118, 549-565 (2009)
59. Koch, C.&Stratling, W. H.DNAbinding of methyl-CpG-binding protein MeCP2 in human MCF7 cells. Biochemistry 43, 5011-5021 (2004)
60. Chatagnon, A. et al. Preferential binding of the methyl-CpG binding domain protein 2 atmethylated transcriptional start site regions. Epigenetics 6, 1295-1307 (2011)
61. Yu, W. et al. Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell. PLoS One 6, e29450 (2011)
62. Serre, D., Lee, B. H. & Ting, A. H. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res 38, 391-399 (2010)
63. Laird, P. W. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 11, 191-203 (2010)
64. Lee, E. et al. Landscape of Somatic Retrotransposition in Human Cancers. Science 337, 967-971 (2012)
65. Howell Jr, P. M. et al. Epigenetics in human melanoma. Cancer Control 16, 200-218 (2009)
66. Higgins, M. E., Claremont, M., Major, J. E., Sander, C. & Lash, A. E. CancerGenes: a gene selection resource for cancer genome projects. Nucleic Acids Res 35, D721-726 (2007)
67. Schmid, C. D., Perier, R., Praz, V. & Bucher, P. EPD in its twentieth year: towards complete promoter coverage of selected model organisms. Nucleic Acids Res 34, D82-85 (2006)
68. Bild, A. H. et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357 (2006)
69. Barabasi, A. L. & Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nat Rev Genet 5, 101-113 (2004)
70. Kim, J. H. et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 21, 1028-1041 (2011)
71. Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43, 768-775 (2011)
72. Bizik, J., Lizonova, A., Stephens, R. W., Grofova, M. & Vaheri, A. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion. Cell Regul 1, 895-905 (1990)
73. Lizonova, A., Bizik, J., Grofova, M.&Vaheri, A. Coexpression of tumor-associated alpha 2-macroglobulin and growth factors in human melanoma cell lines. J Cell Biochem 43, 315-325 (1990)
74. Grofova, M., Bizik, J., Lizonova, A. & Kieler, J. Alpha-2-macroglobulin is not synthesized by human urothelial cell lines in vitro. Neoplasma 37, 149-158 (1990)
75. Givant-Horwitz, V., Davidson, B.&Reich, R. Laminin-induced signaling in tumor cells: the role of the M(r) 67, 000 laminin receptor. Cancer Res 64, 3572-3579 (2004)
76. Mazar, J. et al. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5, e13779 (2010)
77. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 10, R25 (2009)
78. Zhang, Y. et al.Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137 (2008)
79. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res 19, 1639-1645 (2009)
80. Trapnell, C., Pachter, L.&Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009)
81. Wu, H., Caffo, B., Jaffee, H. A., Irizarry, R. A. & Feinberg, A. P. Redefining CpG islands using hidden Markov models. Biostatistics 11, 499-514 (2010)
82. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22, 1775-1789 (2012)
83. Meyer, L. R. et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41, D64-69 (2013)
84. Kong, L. et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res 35, W345-349 (2007)
85. Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E. & Mattick, J. S. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Research 39, D146-D151 (2011)
86. Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38, W214-220 (2010)
87. Beissbarth, T. & Speed, T. P. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 20, 1464-1465 (2004)
88. Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2, 2366-2382 (2007)